Orexo and GoGoMeds Partner to Bring Digital Therapies to Populations Battling Addiction and Depression with Limited Support Options
Orexo and GoGoMeds have formed a partnership to make the scientifically-proven, digital therapies deprexis® and vorvida® available for the treatment of depression and management of problematic alcohol misuse respectively. OXD01, a digital therapy for the treatment of opioid use disorders, will also be available in the US in Q4 2020 through the partnership. The partnership between Orexo and GoGoMeds will focus on making these solutions available through various complementary addiction services at the US state level, including court systems, as well as through private sector employers and other partners.
#institution
#cbt